Foto Prof. Dr. Heiko Nathues

Prof. Dr. Heiko Nathues

Department Klinische Veterinärmedizin Schweineklinik Universität Bern

„Enzootische Pneumonie beim Schwein – Erkenntnisse aus der Vergangenheit und Ideen für die Zukunft.“

Überblick über bisherige Arbeitsschwerpunkte

Heiko Nathues graduated from the University of Veterinary Medicine in Hannover, Germany in 2004. He spent some month in a specialised pig practice in Northern Germany. Until 2011 he was employed at the Field Station for Epidemiology of the University of Veterinary Medicine Hannover in Bakum, where he also obtained his Dr. med. vet. and his PhD. The latter one was assigned with the ‘Konrad-Boegel- Award for veterinary epidemiology and veterinary public health’. During his time in Bakum he built up from the scratch a laboratory for molecular biology, for serology and for genetic engineering. Awarded with a Marie-Curie Intra-European-Fellowship he joined the Veterinary Epidemiology, Economics and Public Health Group of the Royal Veterinary College in London, from 2011 to 2013. He was involved in development of within-herd transmission models for pig diseases and contributed to various research projects dedicated to porcine health management. In 2013 he received the venia legendi for ‘Pig diseases and population medicine’ from the University of Veterinary Medicine Hannover. Since then, he is a professor at the Vetsuisse Faculty of the University of Bern, Switzerland, where he is heading the clinic for swine. His primary areas of interest are diagnosis, epidemiology and control of porcine infectious diseases. Current research is focused on modelling diseases in pig herds, the improvement of diagnostic methods and the determination of the efficacy of methods to control the disease.


Die Schweineklinik der Vetsuisse Fakultät in Bern bearbeitet folgende Forschungsschwerpunkte:

  • Erfassung, Bewertung und Verbesserung von Tiergesundheit in Schweinebeständen
  • Monitoring, Bekämpfung und ggf. Eradikation ausgewählter Infektionskrankheiten
  • Strategien zur Reduktion der Anwendung von Antibiotika und Verbesserung des Verbraucherschutzes